Buscar
Mostrando ítems 1-1 de 1
Clinical, patient-reported, and ultrasound outcomes from an open-label, 12-week observational study of certolizumab pegol in spanish patients with rheumatoid arthritis with or without prior anti-TNF exposure
(Elsevier, 2018-09-17)
[Abstract] Objectives: To assess the effectiveness and safety of certolizumab pegol (CZP) in Spanish patients with RA.
Materials and methods: SONAR (NCT01526434), a 12-week, open-label, prospective, observational, ...